Review





Similar Products

prrx1  (Novus Biologicals)
94
Novus Biologicals prrx1
Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ
Prrx1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prrx1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
prrx1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
achromatic lens 45407  (Edmund Optics)
90
Edmund Optics achromatic lens 45407
Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ
Achromatic Lens 45407, supplied by Edmund Optics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/achromatic lens 45407/product/Edmund Optics
Average 90 stars, based on 1 article reviews
achromatic lens 45407 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
anti prrx1  (Novus Biologicals)
94
Novus Biologicals anti prrx1
Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ
Anti Prrx1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti prrx1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti prrx1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
anti rfp  (Novus Biologicals)
94
Novus Biologicals anti rfp
Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ
Anti Rfp, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti rfp/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti rfp - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
m aromaticivorans  (DSMZ)
86
DSMZ m aromaticivorans
Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ
M Aromaticivorans, supplied by DSMZ, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m aromaticivorans/product/DSMZ
Average 86 stars, based on 1 article reviews
m aromaticivorans - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

Image Search Results


Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ

Journal: Cancer Research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells

doi: 10.1158/0008-5472.can-21-4145

Figure Lengend Snippet: Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV-HER2 ECC acini. A, qPCR for the indicated genes in siControl versus siNr2f1 MMTV-HER2 ECC acini. N ¼ 3 to 9. B, Percentage of E-cadherinþ acini by IF. N ¼ 3. C, Percentage of TWIST1þ cells per acinus. N ¼ 2. D, Percentage of PRRX1þ

Article Snippet: Antibodies used were: E-cadherin (BD Biosciences #610181; RRID:AB_397580); b-catenin (BD Biosciences 610153; RRID:AB_397554); laminin 5 (Progen #10765; RRID:AB_2909803); CK14 (Biolegend #905301; RRID:AB_2565048); 1:25 NR2F1 (Abcam #ab181137; RRID: AB_2890250); PRRX1 (Novus Biologicals #NBP2–13816; RRID: AB_2909804); TWIST (Sigma-Aldrich #ABD29; RRID:AB_10807559); 1:50 HER2 (R&D Systems #OP15L; RRID:AB_2099415); PH3 (Cell Signaling Technology #9701S; RRID:AB_331535); SNAIL (Novus Biologicals #NBP1–80022; RRID:AB_11039370); CK18 (Progen #GPCK-18; RRID:AB_2909805); PanCK (eBioscience #42–9003–80; RRID:AB_10804753); vimentin (R&D Systems #MAB2105; RRID: AB_2241653).

Techniques: